Breast Screening
Cervical Screening
Bowel Screening
Diabetic Retina Screening

Latest News
  • Diabetic RetinaScreen is on target to complete first round of diabetic retinopathy screening for people with diabetes aged 12 and over
    - 25 August 2014
  • Screening programme Diabetic RetinaScreen has begun new information and advertising campaign
    - 11 June 2014
  • BowelScreen delighted to receive MSD Crystal Clear Health Literacy award
    - 26 May 2014
  • *
  • NCSS Accessibility
  • Screening Promotion


Mission Statement

The National Cancer Screening Service will develop and provide quality cancer screening programmes for people in Ireland.
Read more ...

Welcome to the National Cancer Screening Service Website

The National Cancer Screening Service was established by the Minister for Health and Children in January 2007. The establishment followed the launch of a Strategy for Cancer Control in Ireland 2006 (pdf file), which advocates a comprehensive cancer control policy programme in Ireland.

The Strategy examined prevention, screening, detection, treatment and management of cancer in Ireland in coming years and recommended the former Board of the National Cancer Screening Service.

The National Cancer Screening Service (NCSS) encompasses BreastCheck - The National Breast Screening Programme, CervicalCheck - The National Cervical Screening Programme and BowelScreen – The National Bowel Screening Programme. The NCSS is also responsible for developing Diabetic RetinaScreen – The National Diabetic Retinal Screening Programme.

The former Board of the NCSS also had a mandate that included a policy development and advisory role to the Minister for Health and Children relating to other potential cancer screening programmes.

At the request of the Minister for Health and Children the former Board of the NCSS undertook a review of the Human Papolloma Virus (HPV) vaccines and reviews of the rationale for the introduction of national population based bladder, prostate and lung cancer screening programmes.

The NCSS has also established an Expert Group on Hereditary Cancer Risk and has hosted the first ever interagency lung cancer research forum.

Further information on all these developments is available here.

Media Calls:
For press calls please call the Communications Team 01 865 9300